Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Novel device to monitor transplanted organs for early signs of rejection

Published 08-09-2023, 07:06 pm
Novel device to monitor transplanted organs for early signs of rejection

New York, Sep 8 (IANS) Scientists, including one of Indian-origin, have developed the first-ever electronic device that monitors the health of transplanted organs in real time by tracking the its temperature. The device offers continuous monitoring by tracking the organ's temperature. When temperatures change, the device sends an alert to a smartphone or tablet in real time.

The tiny 0.3 centimetres wide device can directly be fitted on a transplanted kidney and can detect temperature irregularities associated with inflammation and other body responses that arise with transplant rejection.

"Organ temperature fluctuates over a daily cycle under normal circumstances. We observed abnormal higher frequency temperature variations occurring over periods of 8 and 12 hours in cases of transplant rejection," said Surabhi Madhvapathy, a postdoctoral researcher at Northwestern University in the US.

The device contains a highly sensitive thermometer, which can detect incredibly slight (0.004 degrees Celsius) temperature variations on the kidney and also measures blood flow, although the researchers found temperature was a better indicator of rejection.

"If rejection is detected early, physicians can deliver anti-rejection therapies to improve the patient’s health and prevent them from losing the donated organ. In worst-case scenarios, if rejection is ignored, it could be life threatening," said John A. Rogers, bioelectronics researcher at Northwestern.

"The earlier you can catch rejection and engage therapies, the better," he added.

The scientists tested the device on a small animal model with transplanted kidneys and found the device detected warning signs of rejection up to three weeks earlier than current monitoring methods.

Current transplanted organs monitoring methods are not perfect and time consuming.

The current "gold standard" for detecting rejection is a biopsy, in which a physician uses a long needle to extract a tissue sample from the transplanted organ and then analyses the sample for signs of impending rejection.

This method carries risks of multiple complications, including bleeding, infection, pain and even inadvertent damage to nearby tissues.

--IANS

ya/rvt/svn

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.